Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms

Blood Cancer Journal

Volumn 2, Issue 9, 2012, Pages

  Kobune, M ^a   Iyama, S ^a   Kikuchi, S ^a   Horiguchi, H ^a   Sato, T ^a   Murase, K ^a   Kawano, Y ^a   Takada, K ^a   Ono, K ^a   Kamihara, Y ^a   Hayashi, T ^a   Miyanishi, K ^a   Sato, Y ^a   Takimoto, R ^a   Kato, J ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acute myeloid leukemia (AML); human hedgehog interacting protein (HHIP); myelodysplastic syndrome (MDS); stromal cells

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD4 ANTIGEN; HEDGEHOG INTERACTING PROTEIN; PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER GROWTH; CARCINOGENESIS; CELL ACTIVITY; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMETHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MICROENVIRONMENT; MYELODYSPLASTIC SYNDROME; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; STROMA CELL;

EID: 84871090517     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.36     Document Type: Article

References (50)

1. Deguchi K, Gilliland DG. Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia 2002; 16: 740-744.
2. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
3. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365: 1384-1395.
4. Wang L, Gural A, Sun XJ, Zhao X, Perna F, Huang G et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 2011; 333: 765-769.
5. Blau O, Baldus CD, Hofmann WK, Thiel G, Nolte F, Burmeister T et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood 2011; 118: 5583-5592.
6. Santamaria C, Muntion S, Roson B, Blanco B, Lopez-Villar O, Carrancio S et al. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndromes patients. Haematologica 2012; 97: 1218-1224.
7. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2011; 464: 852-857.
8. Schmidt T, Kharabi Masouleh B, Loges S, Cauwenberghs S, Fraisl P, Maes C et al. Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib- Resistant Bcr-Abl1() Leukemia. Cancer Cell 2011; 19: 740-753.
9. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2: 172-180.
10. Kobune M, Kato J, Kawano Y, Sasaki K, Uchida H, Takada K et al. Adenoviral vectormediated transfer of the Indian hedgehog gene modulates lymphomyelopoiesis in vivo. Stem Cells 2008; 26: 534-542.
11. Kobune M, Ito Y, Kawano Y, Sasaki K, Uchida H, Nakamura K et al. Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID-beta2m-/- repopulating cells. Blood 2004; 104: 1002-1009.
12. Gao J, Graves S, Koch U, Liu S, Jankovic V, Buonamici S et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 2009; 4: 548-558.
13. Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al. Expansion of Bcr-Ablpositive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14: 238-249.
14. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776-779.
15. Gal H, Amariglio N, Trakhtenbrot L, Jacob-Hirsh J, Margalit O, Avigdor A et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia 2006; 20: 2147-2154.
16. Essers MA, Trumpp A. Targeting leukemic stem cells by breaking their dormancy. Mol Oncol 2010; 4: 443-450.
17. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol 2008; 26: 2806-2812.
18. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOGGLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165-172.
19. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002; 297: 1559-1561.
20. Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S et al. Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One 2010; 5: e15262.
21. Kobune M, Takimoto R, Murase K, Iyama S, Sato T, Kikuchi S et al. Drug resistance is dramatically restored by hedgehog inhibitors in CD34 leukemic cells. Cancer Sci 2009; 100: 948-955.
22. Chuang PT, McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999; 397: 617-621.
23. Bosanac I, Maun HR, Scales SJ, Wen X, Lingel A, Bazan JF et al. The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol 2009; 16: 691-697.
24. Martin ST, Sato N, Dhara S, Chang R, Hustinx SR, Abe T et al. Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther 2005; 4: 728-733.
25. Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K et al. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 2007; 213: 131-139.
26. Kawano Y, Kobune M, Yamaguchi M, Nakamura K, Ito Y, Sasaki K et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 2003; 101: 532-540.
27. Kobune M, Kato J, Chiba H, Kawano Y, Tanaka M, Takimoto R et al. Telomerized human bone marrow-derived cell clones maintain the phenotype of hematopoietic- supporting osteoblastic and myofibroblastic stromal cells after long-term culture. Exp Hematol 2005; 33: 1544-1553.
28. Kobune M, Kawano Y, Takahashi S, Takada K, Murase K, Iyama S et al. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells. Exp Hematol 2008; 36: 1121-1131.
29. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term cultureinitiating cells after incubation on human bone marrow stromal cells. Blood 1997; 90: 641-650.
30. Cammenga J, Niebuhr B, Horn S, Bergholz U, Putz G, Buchholz F et al. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation. Cancer Res 2007; 67: 537-545.
31. Roman-Gomez J, Castillejo JA, Jimenez A, Cervantes F, Boque C, Hermosin L et al. Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. J Clin Oncol 2003; 21: 1472-1479.
32. Kobune M, Chiba H, Kato J, Kato K, Nakamura K, Kawano Y et al. Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Mol Cancer Ther 2007; 6: 1774-1784.
33. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999; 21: 103-107.
34. Tormin A, Li O, Brune JC, Walsh S, Schutz B, Ehinger M et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011; 117: 5067-5077.
35. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989; 140: 323-334.
36. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-2036.
37. Koch CM, Suschek CV, Lin Q, Bork S, Goergens M, Joussen S et al. Specific age-associated DNA methylation changes in human dermal fibroblasts. PLoS One 2011; 6: e16679.
38. Bergsagel PL, Kuehl WM. Comprehensive Identification of Somatic Mutations in Chronic Lymphocytic Leukemia. Cancer Cell 2011; 20: 5-7.
39. Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007; 13: 944-951.
40. Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007; 104: 4048-4053.
41. Detmer K, Walker AN, Jenkins TM, Steele TA, Dannawi H. Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of hedgehog signaling. Blood Cells Mol Dis 2000; 26: 360-372.
42. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164-1172.
43. Mar BG, Amakye D, Aifantis I, Buonamici S. The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis. Leukemia 2011; 25: 1665-1673.
44. Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 2009; 4: 559-567.
45. Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X et al. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples. J Neurooncol 2011; 103: 287-296.
46. Graubert T, Walter MJ. Genetics of myelodysplastic syndromes: new insights. Hematology Am Soc Hematol Educ Program 2011; 2011: 543-549.
47. Fabiani E, Leone G, Giachelia M, D'Alo F, Greco M, Criscuolo M et al. Analysis of genome-wide methylation and gene expression induced by 5-aza-20-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leuk Lymphoma 2010; 51: 2275-2284.
48. Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H et al. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res 2011; 35: 516-521.
49. Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O et al. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood 2011; 118: 5573-5582.
50. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17: 225-234.